<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id><journal-id journal-id-type="publisher-id">BMRI</journal-id><journal-title-group><journal-title>BioMed Research International</journal-title></journal-title-group><issn pub-type="ppub">2314-6133</issn><issn pub-type="epub">2314-6141</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5529630</article-id><article-id pub-id-type="doi">10.1155/2017/7518789</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>
<italic>NPHS2</italic> Mutations: A Closer Look to Latin American Countries</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6508-8571</contrib-id><name><surname>Guaragna</surname><given-names>Mara Sanches</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lutaif</surname><given-names>Anna Cristina G. B.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Maciel-Guerra</surname><given-names>Andr&#x000e9;a T.</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Belangero</surname><given-names>Vera M. S.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2991-7678</contrib-id><name><surname>Guerra-J&#x000fa;nior</surname><given-names>Gil</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0521-9100</contrib-id><name><surname>De Mello</surname><given-names>Maricilda P.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Center for Molecular Biology and Genetic Engineering (CBMEG), State University of Campinas (UNICAMP), Campinas, SP, Brazil</aff><aff id="I2">
<sup>2</sup>Integrated Center of Pediatric Nephrology (CIN), Department of Pediatrics, School of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, SP, Brazil</aff><aff id="I3">
<sup>3</sup>Department of Medical Genetics, School of Medical Sciences (FCM), Interdisciplinary Group for the Study of Sex Determination and Differentiation (GIEDDS), School of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, SP, Brazil</aff><aff id="I4">
<sup>4</sup>Interdisciplinary Group for the Study of Sex Determination and Differentiation (GIEDDS), Pediatrics Endocrinology, Department of Pediatrics, School of Medical Sciences (FCM), State University of Campinas, UNICAMP, Campinas, SP, Brazil</aff><author-notes><corresp id="cor1">*Mara Sanches Guaragna: <email>mara.guaragna@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editor: Andreas Kronbichler</p></fn></author-notes><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="epub"><day>12</day><month>7</month><year>2017</year></pub-date><volume>2017</volume><elocation-id>7518789</elocation-id><history><date date-type="received"><day>3</day><month>3</month><year>2017</year></date><date date-type="rev-recd"><day>2</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>8</day><month>6</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Mara Sanches Guaragna et al.</copyright-statement><copyright-year>2017</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Nephrotic syndrome is one of the most common kidney pathologies in childhood, being characterized by proteinuria, edema, and hypoalbuminemia. In clinical practice, it is divided into two categories based on the response to steroid therapy: steroid-sensitive and steroid resistant. Inherited impairments of proteins located in the glomerular filtration barrier have been identified as important causes of nephrotic syndrome, with one of these being podocin, coded by<italic> NPHS2</italic> gene.<italic> NPHS2</italic> mutations are the most frequent genetic cause of steroid resistant nephrotic syndrome. The aim of this review is to update the list of<italic> NPHS2</italic> mutations reported between June 2013 and February 2017, with a closer look to mutations occurring in Latin American countries.</p></abstract><funding-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</funding-source><award-id>2012/51109-9</award-id><award-id>2012/51109-0</award-id><award-id>2013/24088-4</award-id></award-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico</funding-source><award-id>478444/08-7</award-id><award-id>141072/2010</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>In the high-throughput sequencing era, new candidate genes associated with monogenic and genetic heterogeneous diseases such as steroid resistant nephrotic syndrome (SRNS) are piling up [<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>]. However, mutations in the three main genes (<italic>NPHS1</italic>,<italic> NPHS2</italic>, and exons 8 and 9 of<italic> WT1</italic> gene) are still the most frequent molecular cause of SRNS in childhood and adolescence. More than 200<italic> NPHS2</italic> (OMIM <sup><italic>&#x02217;</italic></sup>604766) gene mutations are registered in HGMD Professional 2017.1 (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk">http://www.hgmd.cf.ac.uk</ext-link>) and 127 in the HGMD Public 2017.1 associated with familial and sporadic forms of SRNS.</p><p>SRNS is one of the most common kidney pathologies in childhood, being characterized by proteinuria, edema, and hypoalbuminemia. The most frequent renal histological feature associated with SRNS is focal segmental glomerulosclerosis (FSGS). Almost 40% of SRNS/FSGS children develop end-stage renal disease (ESRD) before adulthood and may receive a kidney transplant, with a 10 to 50% risk of recurrence of FSGS in the allograft kidney [<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>]. Although the pathogenesis of NS is not yet completely understood, much has been learnt about the glomerular filtration barrier (GFB) which is composed of three layers: the fenestrated capillary endothelial cells; the glomerular basement membrane (GBM); and the podocytes, specialized cells with interdigitating foot processes that are interconnected to form a slit diaphragm (SD) membrane, a multiprotein signaling complex that controls the ultrafiltration in this dynamic structure [<xref rid="B10" ref-type="bibr">10</xref>]. Nephrotic protein leakage may occur as a result from damage in one of these GFB components [<xref rid="B11" ref-type="bibr">11</xref>], although functional pathways specifically in the podocyte have revealed this cell as the key component of the pathogenesis of SRNS [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>].</p><p>More than 50 genes have been identified so far, associated with SRNS of congenital (0&#x02013;3 months), infantile (4&#x02013;12 months), childhood/adolescence (1&#x02013;18 years), or adult onset [<xref rid="B6" ref-type="bibr">6</xref>]. In 2007, Hinkes et al. [<xref rid="B14" ref-type="bibr">14</xref>] screened the four genes<italic> NPHS1</italic> (OMIM <sup><italic>&#x02217;</italic></sup>602716),<italic> NPHS2</italic> (OMIM <sup><italic>&#x02217;</italic></sup>604766),<italic> WT1</italic> (OMIM <sup><italic>&#x02217;</italic></sup>607102), and<italic> LAMB2</italic> (OMIM <sup><italic>&#x02217;</italic></sup>150325) in a large European cohort of 89 children from 80 families with NS manifesting in the first year of life. They detected disease-causing mutations in one of the four genes in 66.3% of the families, 84.8% of congenital onset, and 44.1% of infantile onset. Seven years later, in 2014, Sadowski et al. [<xref rid="B5" ref-type="bibr">5</xref>] screened 27 genes associated with SRNS in 1783 families from an international cohort study (107 members from 30 countries). The eight larger contributing centers were Germany, Switzerland, Turkey, Egypt, Saudi Arabia, Los Angeles, Ann Arbor, and India but many other centers participated, including Argentina representing South America with 16 families. The main conclusion was that a monogenic cause was detected in 29.5% of the SRNS cases (0&#x02013;25 years) in one of the 27 genes analyzed. After a detailed analysis of mutation distribution by gene and by age of onset,<italic> NPHS2</italic> mutations were the most frequent (5.7% to 12.7%) in patients with SRNS onset between 1 and 18 years old.</p><p>Mutations in<italic> NPHS2</italic> gene, located at 1q25-31, are the most common cause of SRNS in childhood and were first described by Boute et al. (2000) [<xref rid="B15" ref-type="bibr">15</xref>].<italic> NPHS2</italic> coding region encompasses 1,149&#x02009;bp, has 8 exons, and encodes a 383-amino-acid protein with 42&#x02009;kD, called podocin, which is expressed in fetal and mature kidney [<xref rid="B15" ref-type="bibr">15</xref>]. Podocin is predicted to have a hairpin-like structure, with both C- and N-terminal domains facing cytosol and one short transmembrane domain [<xref rid="B16" ref-type="bibr">16</xref>]. In addition to its role in anchoring nephrin and CD2AP (OMIM <sup><italic>&#x02217;</italic></sup>604241) to the SD, podocin forms homoligomer complexes that bind with cholesterol in lipid rafts, where it may act as a scaffolding/targeting/signaling protein [<xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B19" ref-type="bibr">19</xref>].<italic> NPHS2</italic> mutations initially found in autosomal-recessive inheritance familial cases [<xref rid="B15" ref-type="bibr">15</xref>] and further in sporadic SRNS cases [<xref rid="B20" ref-type="bibr">20</xref>] as well represent 40% and 6&#x02013;17% of these cases, respectively [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B22" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]. In 2013, Bouchireb et al. [<xref rid="B24" ref-type="bibr">24</xref>], in a detailed and complete review, presented a list of<italic> NPHS2</italic> mutations, polymorphisms, and variants of unknown significance published from October 1999 to September 2013. In that review they identified 25 novel pathogenic mutations in addition to the 101 already registered in the mutation database at that time. The mutations were distributed along the entire<italic> NPHS2</italic> gene, with no preferential hotspot.</p><p>The aim of this review is to update the list of<italic> NPHS2</italic> mutations reported in the last few years around the world, with a closer look to mutations occurring in Latin American countries.</p></sec><sec id="sec2"><title>2. <italic>NPHS2</italic> Mutations Overview</title><p>We searched for articles reporting<italic> NPHS2</italic> mutations associated with SRNS in childhood and adolescence that were published from June 2013 to February 2017. The key words<italic> &#x0201c;NPHS2&#x0201d;</italic>, &#x0201c;<italic>NPHS2</italic> mutations&#x0201d;, &#x0201c;podocin&#x0201d; and &#x0201c;steroid resistant nephrotic syndrome genetics&#x0201d; were used in PubMed databank. We further looked for variants/mutations that were not annotated in open-access databases such as public HGMD (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>) and GnomeAD Browser (<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org">http://gnomad.broadinstitute.org</ext-link>) or in Leiden Open Variation Database (<ext-link ext-link-type="uri" xlink:href="https://www.lovd.nl/NPHS2">https://www.lovd.nl/NPHS2</ext-link>). For nonsynonymous variants, we classified them as deleterious or benign according to in silico prediction tools (PolyPhen-2 and SIFT) [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>]. For splicing variants, we performed splice-site prediction by BDGP neural network [<xref rid="B27" ref-type="bibr">27</xref>].</p><p>Thirty-nine variants, among them 25 missenses, four nonsenses, three splice-sites, four frameshifts, and three in the promoter region were published from June 2013 to February 2017 in a total of 109 out of 829 SRNS patients in many countries: China (Wang et al., 2017) [<xref rid="B28" ref-type="bibr">28</xref>]; India (Jaffer et al., 2014; Dhandapani et al. 2017; Ramanathan et al. 2017) [<xref rid="B30" ref-type="bibr">29</xref>&#x02013;<xref rid="B29" ref-type="bibr">31</xref>]; Italy (Benetti et al., 2013) [<xref rid="B32" ref-type="bibr">32</xref>]; Iran (Basiratnia et al., 2013) [<xref rid="B33" ref-type="bibr">33</xref>]; United Kingdom (Jain et al., 2014) [<xref rid="B34" ref-type="bibr">34</xref>]; United States of America (Laurin et al., 2014; Phelan et al., 2015) [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>]; Poland (Kuleta et al., 2014) [<xref rid="B37" ref-type="bibr">37</xref>]; Finland (Suvanto et al., 2016) [<xref rid="B38" ref-type="bibr">38</xref>]; Saudi Arabi (Kari et al., 2013) [<xref rid="B39" ref-type="bibr">39</xref>]; Japan (Ogino et al., 2015) [<xref rid="B40" ref-type="bibr">40</xref>]; Mexico (Carrasco-Miranda et al., 2013) [<xref rid="B41" ref-type="bibr">41</xref>]; Chile (Azocar et al., 2016) [<xref rid="B42" ref-type="bibr">42</xref>]; and Brazil (Guaragna et al., 2015) [<xref rid="B43" ref-type="bibr">43</xref>]. Ten out of those 39 mutations were unique and had not been annotated in public HGMD (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>) or in GnomeAD Browser (<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org">http://gnomad.broadinstitute.org</ext-link>) or in the Leiden Open Variation Database (<ext-link ext-link-type="uri" xlink:href="https://www.lovd.nl/NPHS2">https://www.lovd.nl/NPHS2</ext-link>): six were missenses, three were located in splice-site regions, and two were frameshifts (<xref ref-type="table" rid="tab1">Table 1</xref>). We searched GnomaAD Browser for all the variants compiled in <xref ref-type="table" rid="tab1">Table 1</xref> as well as for other variants such those reported in Mexico (p.Leu142Pro), Chile and Brazil (p.Ala284Val), and Brazil (p.Val260Glu), observing frequency, racial ethnicity, and geographical provenience. Only p.Ala284Val and p.Val260Glu were registered at GnomaAD Browser, but no allele counted was from Latin America population for both of them.</p></sec><sec id="sec3"><title>3. Missense Mutations</title><p>Four out of the five missenses were described in homozygosity in South Indian SRNS patients (p.Ser46Pro, p.Leu167Pro, p.Pro175Ser, and p.Pro316Ser) [<xref rid="B30" ref-type="bibr">29</xref>, <xref rid="B31" ref-type="bibr">30</xref>]. The fifth missense, p.Leu139Arg, was identified in two Mexican children with NS, one SRNS, and one SSNS [<xref rid="B41" ref-type="bibr">41</xref>]. As in silico predictions were not performed for those variants in their original publications, we investigated their pathogenicity by predictive tools available, such as SIFT and PolyPhen-2. Both p.Leu139Arg and p.Pro316Ser variants were predicted as damaging by SIFT and PolyPhen-2 (<xref ref-type="table" rid="tab1">Table 1</xref>). At the moment, these five missense variants should be considered as variants of unknown significance and only after proper functional studies they can be associated with SRNS.</p></sec><sec id="sec4"><title>4. Splice-Site Mutations</title><p>Three splice-site mutations that were not registered in any of the three searched databases have been identified (<xref ref-type="table" rid="tab1">Table 1</xref>). The homozygous splice-site mutation c.451+3A&#x0003e;T whose effect on podocin protein was evaluated by renal mRNA analysis demonstrated exon 3 skipping that led to a premature termination codon (p.Val128Phefs<sup><italic>&#x02217;</italic></sup>28). This mutation was originally identified by Benetti et al. [<xref rid="B32" ref-type="bibr">32</xref>] in an Italian girl with SRNS. Either c.535-1G&#x0003e;A or c.738+2T&#x0003e;C were described by Wang et al. [<xref rid="B28" ref-type="bibr">28</xref>] in compound heterozygosis with another known<italic> NPHS2</italic> mutation in two nonrelated SRNS Chinese children. They evaluated the conservation of variant sites using PhyloP Primates tool that resulted in scores of 4.481 and 3.839 for c.535-1G&#x0003e;A and c.738+2T&#x0003e;C, respectively, indicating high degree of conservation at these sites. They also evaluated those variants using Mutation Taster that classified them as damaging. Nevertheless, they did not use the BDGP Splice Site Prediction by Neural Network in silico tool to predict the splicing recognition sites; therefore, we performed this analysis and the resulting prediction is shown in <xref ref-type="table" rid="tab1">Table 1</xref>.</p></sec><sec id="sec5"><title>5. Frameshift Mutations</title><p>Two small deletions were described: one (p.Ser329 = fs<sup><italic>&#x02217;</italic></sup>14) was found in heterozygosis in five SRNS individuals from the same Finnish family, with early-onset, slow progression, and dominant inheritance pattern [<xref rid="B38" ref-type="bibr">38</xref>]; the other (p.Lis239Argfs<sup><italic>&#x02217;</italic></sup>13) was identified by our group in two Brazilian sisters with early-onset SRNS in association with the p.Val260Glu missense [<xref rid="B43" ref-type="bibr">43</xref>].</p></sec><sec id="sec6"><title>6. <italic>NPHS2</italic> Mutations in the World with a Closer Look to Latin America</title><p>Population studies from different countries, mainly from Europe, South Asia, and North America, revealed that the prevalence of<italic> NPHS2</italic> mutations in children with SRNS may vary according to ethnicity. It appears to be frequent among Americans and Turkish [<xref rid="B22" ref-type="bibr">21</xref>, <xref rid="B44" ref-type="bibr">44</xref>] (26% and 24.7%, resp.) but not as frequent among Greek [<xref rid="B45" ref-type="bibr">45</xref>], Chinese [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B46" ref-type="bibr">46</xref>], Indian [<xref rid="B47" ref-type="bibr">47</xref>], Japanese [<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B48" ref-type="bibr">48</xref>], Pakistani [<xref rid="B49" ref-type="bibr">49</xref>], and Korean [<xref rid="B50" ref-type="bibr">50</xref>] patients (9%, 4.3%, 4%, 4%, 3.4%, and 0%, resp.). Recently a large multicentric study was performed with samples from 1783 SRNS families from eight contributing centers in which twenty-seven SRNS associated genes were sequenced. Disease-causing mutations were identified in different genes; however, mutations in<italic> NPHS2 </italic>were more frequent [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. Some of them, with a high frequency in particular geographical regions, are considered as founder alleles for<italic> NPHS2</italic>: p.Arg138Gln and p.Gly140Aspfs<sup><italic>&#x02217;</italic></sup>41 are predominant in Europe; p.Pro118Leu in Turkey; p.Val180Met in North Africa; p.Arg138<sup><italic>&#x02217;</italic></sup> in Israel and Arabian countries; p.Val260Glu in Oman, Arabia; and p.Met1? and Asn199Lysfs<sup><italic>&#x02217;</italic></sup>14 in Egypt [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B15" ref-type="bibr">15</xref>].</p><p>The contribution of Latin American countries to genetic studies in SRNS is scarce. Searches for<italic> NPHS2</italic> mutations had been performed mainly in three countries: Mexico, Chile, and Brazil (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In Mexico, only the 3rd exon of<italic> NPHS2</italic> was sequenced in eight SRNS and five SSNS children [<xref rid="B41" ref-type="bibr">41</xref>]. The heterozygous p.Leu139Arg variant was identified in two patients, one SRNS and one SSNS; therefore, it was considered as a variant of unknown significance. In Chile, Azocar et al. [<xref rid="B42" ref-type="bibr">42</xref>] performed a molecular study in SRNS children and found<italic> NPHS2</italic> mutations in 21%. The mutations identified were homozygosis for p.Pro341Ser in one patient and compound heterozygosis for p.Arg229Gln and p.Ala284Val in six patients [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B51" ref-type="bibr">51</xref>]. In Brazil, our group performed the molecular analysis of<italic> NPHS2</italic> in 27 SRNS children and identified disease-causing mutations in 14.8%. We identified the following associations: the [p.Ala284Val];[p.Arg229Gln] and [p.Ala284Val(;)p.Arg229Gln] in two sporadic unrelated patients with late-onset SRNS; the [p.Glu310Lys];[p.Arg229Gln] association in one sporadic patient with early-onset SRNS, and the [p.Lis239Argfs<sup><italic>&#x02217;</italic></sup>13(;)p.Val260Glu] in a familial case also with early-onset SRNS [<xref rid="B43" ref-type="bibr">43</xref>]. Although performed in small samples, those studies suggest that the [p.Ala284Val];[p.Arg229Gln] association is frequent in South American countries. Actually, 13 out of 14 South American families evaluated by Machuca et al. [<xref rid="B52" ref-type="bibr">52</xref>] also carried the [p.Ala284Val];[p.Arg229Gln] association, with one-half presenting the adult onset form of the disease. The p.Val260Glu variant is worth mentioning in this group, which is already considered as a founder allele in Oman, Arabia [<xref rid="B5" ref-type="bibr">5</xref>], and also identified in one of our familial cases. We are not aware of an Arabian ancestrality of this family, but given the highly miscegenated nature of the Brazilian population, we cannot exclude this possibility.</p><p>This review aimed to give a new perspective to Nephrotic Syndrome in Latin American countries, emphasizing the importance of implementing the molecular evaluation of NS, especially investigating mutations on those genes more frequently associated with SRNS in this region. The molecular characterization of SRNS in childhood and adolescence is relevant to guide further treatment, since patients bearing<italic> NPHS2 </italic>mutations may be spared of the undesired side effects of corticosteroids. Additionally, living donor transplantation might be considered since SRNS patients with homozygous or compound heterozygous mutations in<italic> NPHS2 </italic>have reduced risks for recurrence of FSGS after renal transplant compared with children without mutations.</p></sec></body><back><ack><title>Acknowledgments </title><p>This work was supported by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (FAPESP, 2012/51109-9 to MPdeM), the Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq, 478444/08-7 to G.G-J and 141072/2010 to MSG), and Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (FAPESP, 2012/51109-0 to MPdeM and 2013/24088-4 to MSG).</p></ack><sec><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname><given-names>H. Y.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Ashraf</surname><given-names>S.</given-names></name><etal/></person-group><article-title>KANK deficiency leads to podocyte dysfunction and nephrotic syndrome</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2015</year><volume>125</volume><issue>6</issue><fpage>2375</fpage><lpage>2384</lpage><pub-id pub-id-type="other">2-s2.0-84930404195</pub-id><pub-id pub-id-type="doi">10.1172/JCI79504</pub-id><pub-id pub-id-type="pmid">25961457</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebarasi</surname><given-names>L.</given-names></name><name><surname>Ashraf</surname><given-names>S.</given-names></name><name><surname>Bierzynska</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Defects of CRB2 cause steroid-resistant nephrotic syndrome</article-title><source><italic>American Journal of Human Genetics</italic></source><year>2015</year><volume>96</volume><issue>1</issue><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="other">2-s2.0-84920736253</pub-id><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.11.014</pub-id><pub-id pub-id-type="pmid">25557779</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovric</surname><given-names>S.</given-names></name><name><surname>Fang</surname><given-names>H.</given-names></name><name><surname>Vega-Warner</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome</article-title><source><italic>Clinical Journal of the American Society of Nephrology</italic></source><year>2014</year><volume>9</volume><issue>6</issue><fpage>1109</fpage><lpage>1116</lpage><pub-id pub-id-type="other">2-s2.0-84919714615</pub-id><pub-id pub-id-type="doi">10.2215/CJN.09010813</pub-id><pub-id pub-id-type="pmid">24742477</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname><given-names>H. Y.</given-names></name><name><surname>Ashraf</surname><given-names>S.</given-names></name><name><surname>Wan</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Mutations in EMP2 cause childhood-onset Nephrotic syndrome</article-title><source><italic>American Journal of Human Genetics</italic></source><year>2014</year><volume>94</volume><issue>6</issue><fpage>884</fpage><lpage>890</lpage><pub-id pub-id-type="other">2-s2.0-84902284568</pub-id><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.04.010</pub-id><pub-id pub-id-type="pmid">24814193</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowski</surname><given-names>C. E.</given-names></name><name><surname>Lovric</surname><given-names>S.</given-names></name><name><surname>Ashraf</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome</article-title><source><italic>Journal of the American Society of Nephrology</italic></source><year>2015</year><volume>26</volume><issue>6</issue><fpage>1279</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1681/asn.2014050489</pub-id><pub-id pub-id-type="pmid">25349199</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bierzynska</surname><given-names>A.</given-names></name><name><surname>McCarthy</surname><given-names>H. J.</given-names></name><name><surname>Soderquest</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management</article-title><source><italic>Kidney International</italic></source><year>2017</year><volume>91</volume><issue>4</issue><fpage>937</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2016.10.013</pub-id><pub-id pub-id-type="pmid">28117080</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>H.</given-names><suffix>II</suffix></name><name><surname>Han</surname><given-names>H. W.</given-names></name><name><surname>Park</surname><given-names>H. W.</given-names></name><etal/></person-group><article-title>Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis</article-title><source><italic>Nephrology Dialysis Transplantation</italic></source><year>2000</year><volume>15</volume><issue>1</issue><fpage>78</fpage><lpage>81</lpage><pub-id pub-id-type="other">2-s2.0-0033981204</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>J. M.</given-names></name><name><surname>Stablein</surname><given-names>D. M.</given-names></name><name><surname>Munoz</surname><given-names>R.</given-names></name><name><surname>Hebert</surname><given-names>D.</given-names></name><name><surname>McDonald</surname><given-names>R. A.</given-names></name></person-group><article-title>Contributions of the transplant registry: The 2006 annual report of the north american pediatric renal trials and collaborative studies (NAPRTCS)</article-title><source><italic>Pediatric Transplantation</italic></source><year>2007</year><volume>11</volume><issue>4</issue><fpage>366</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3046.2007.00704.x</pub-id><pub-id pub-id-type="other">2-s2.0-34247554345</pub-id><pub-id pub-id-type="pmid">17493215</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingulli</surname><given-names>E.</given-names></name><name><surname>Tejani</surname><given-names>A.</given-names></name></person-group><article-title>Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children</article-title><source><italic>Pediatric Nephrology</italic></source><year>1991</year><volume>5</volume><issue>4</issue><fpage>393</fpage><lpage>397</lpage><pub-id pub-id-type="other">2-s2.0-0025773461</pub-id><pub-id pub-id-type="doi">10.1007/BF01453661</pub-id><pub-id pub-id-type="pmid">1911111</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraldsson</surname><given-names>B.</given-names></name><name><surname>Nystr&#x000f6;m</surname><given-names>J.</given-names></name><name><surname>Deen</surname><given-names>W. M.</given-names></name></person-group><article-title>Properties of the glomerular barrier and mechanisms of proteinuria</article-title><source><italic>Physiological Reviews</italic></source><year>2008</year><volume>88</volume><issue>2</issue><fpage>451</fpage><lpage>487</lpage><pub-id pub-id-type="other">2-s2.0-42149122041</pub-id><pub-id pub-id-type="doi">10.1152/physrev.00055.2006</pub-id><pub-id pub-id-type="pmid">18391170</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiggins</surname><given-names>R. C.</given-names></name></person-group><article-title>The spectrum of podocytopathies: a unifying view of glomerular diseases</article-title><source><italic>Kidney International</italic></source><year>2007</year><volume>71</volume><issue>12</issue><fpage>1205</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5002222</pub-id><pub-id pub-id-type="other">2-s2.0-34250006557</pub-id><pub-id pub-id-type="pmid">17410103</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>G.</given-names></name><name><surname>MacHuca</surname><given-names>E.</given-names></name><name><surname>Antignac</surname><given-names>C.</given-names></name></person-group><article-title>Hereditary nephrotic syndrome: A systematic approach for genetic testing and a review of associated podocyte gene mutations</article-title><source><italic>Pediatric Nephrology</italic></source><year>2010</year><volume>25</volume><issue>9</issue><fpage>1621</fpage><lpage>1632</lpage><pub-id pub-id-type="other">2-s2.0-77955012444</pub-id><pub-id pub-id-type="doi">10.1007/s00467-010-1495-0</pub-id><pub-id pub-id-type="pmid">20333530</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovric</surname><given-names>S.</given-names></name><name><surname>Ashraf</surname><given-names>S.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Hildebrandt</surname><given-names>F.</given-names></name></person-group><article-title>Genetic testing in steroid-resistant nephrotic syndrome: when and how?</article-title><source><italic>Nephrology Dialysis Transplantation</italic></source><year>2015</year><pub-id pub-id-type="doi">10.1093/ndt/gfv355</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinkes</surname><given-names>B. G.</given-names></name><name><surname>Mucha</surname><given-names>B.</given-names></name><name><surname>Vlangos</surname><given-names>C. N.</given-names></name><etal/></person-group><article-title>Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)</article-title><source><italic>Pediatrics</italic></source><year>2007</year><volume>119</volume><issue>4</issue><fpage>e907</fpage><lpage>e919</lpage><pub-id pub-id-type="doi">10.1542/peds.2006-2164</pub-id><pub-id pub-id-type="other">2-s2.0-34147096001</pub-id><pub-id pub-id-type="pmid">17371932</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boute</surname><given-names>N.</given-names></name><name><surname>Gribouval</surname><given-names>O.</given-names></name><name><surname>Roselli</surname><given-names>S.</given-names></name><etal/></person-group><article-title>NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome</article-title><source><italic>Nature Genetics</italic></source><year>2000</year><volume>24</volume><issue>4</issue><fpage>349</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1038/74166</pub-id><pub-id pub-id-type="other">2-s2.0-0034034757</pub-id><pub-id pub-id-type="pmid">10742096</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roselli</surname><given-names>S.</given-names></name><name><surname>Gribouval</surname><given-names>O.</given-names></name><name><surname>Boute</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Podocin localizes in the kidney to the slit diaphragm area</article-title><source><italic>American Journal of Pathology</italic></source><year>2002</year><volume>160</volume><issue>1</issue><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="other">2-s2.0-0036144232</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64357-X</pub-id><pub-id pub-id-type="pmid">11786407</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>T. B.</given-names></name><name><surname>Simons</surname><given-names>M.</given-names></name><name><surname>Hartleben</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Molecular basis of the functional podocin-nephrin complex: Mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains</article-title><source><italic>Human Molecular Genetics</italic></source><year>2003</year><volume>12</volume><issue>24</issue><fpage>3397</fpage><lpage>3405</lpage><pub-id pub-id-type="other">2-s2.0-0346121526</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddg360</pub-id><pub-id pub-id-type="pmid">14570703</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>T. B.</given-names></name><name><surname>K&#x000f6;ttgen</surname><given-names>M.</given-names></name><name><surname>Schilling</surname><given-names>B.</given-names></name><name><surname>Walz</surname><given-names>G.</given-names></name><name><surname>Benzing</surname><given-names>T.</given-names></name></person-group><article-title>Interaction with podocin facilitates nephrin signaling</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>45</issue><fpage>41543</fpage><lpage>41546</lpage><pub-id pub-id-type="doi">10.1074/jbc.c100452200</pub-id><pub-id pub-id-type="other">2-s2.0-0035834659</pub-id><pub-id pub-id-type="pmid">11562357</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>K.</given-names></name><name><surname>Simons</surname><given-names>M.</given-names></name><name><surname>Reiser</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2001</year><volume>108</volume><issue>11</issue><fpage>1621</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1172/jci200112849</pub-id><pub-id pub-id-type="other">2-s2.0-0035210324</pub-id><pub-id pub-id-type="pmid">11733557</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karle</surname><given-names>S. M.</given-names></name><name><surname>Uetz</surname><given-names>B.</given-names></name><name><surname>Ronner</surname><given-names>V.</given-names></name><name><surname>Glaeser</surname><given-names>L.</given-names></name><name><surname>Hildebrandt</surname><given-names>F.</given-names></name><name><surname>Fuchshuber</surname><given-names>A.</given-names></name></person-group><article-title>Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome</article-title><source><italic>Journal of the American Society of Nephrology</italic></source><year>2002</year><volume>13</volume><issue>2</issue><fpage>388</fpage><lpage>393</lpage><pub-id pub-id-type="other">2-s2.0-0036151614</pub-id><pub-id pub-id-type="pmid">11805166</pub-id></element-citation></ref><ref id="B22"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berdeli</surname><given-names>A.</given-names></name><name><surname>Mir</surname><given-names>S.</given-names></name><name><surname>Yavascan</surname><given-names>O.</given-names></name><etal/></person-group><article-title>NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic syndrome</article-title><source><italic>Pediatric Nephrology</italic></source><year>2007</year><volume>22</volume><issue>12</issue><fpage>2031</fpage><lpage>2040</lpage><pub-id pub-id-type="other">2-s2.0-36048978116</pub-id><pub-id pub-id-type="doi">10.1007/s00467-007-0595-y</pub-id><pub-id pub-id-type="pmid">17899208</pub-id></element-citation></ref><ref id="B21"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>S.</given-names></name><name><surname>Gribouval</surname><given-names>O.</given-names></name><name><surname>Esquivel</surname><given-names>E. L.</given-names></name><etal/></person-group><article-title>NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence</article-title><source><italic>Kidney International</italic></source><year>2004</year><volume>66</volume><issue>2</issue><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00776.x</pub-id><pub-id pub-id-type="other">2-s2.0-3242795082</pub-id><pub-id pub-id-type="pmid">15253708</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinkes</surname><given-names>B.</given-names></name><name><surname>Vlangos</surname><given-names>C.</given-names></name><name><surname>Heeringa</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome</article-title><source><italic>Journal of the American Society of Nephrology</italic></source><year>2008</year><volume>19</volume><issue>2</issue><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1681/ASN.2007040452</pub-id><pub-id pub-id-type="other">2-s2.0-39049163551</pub-id><pub-id pub-id-type="pmid">18216321</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchireb</surname><given-names>K.</given-names></name><name><surname>Boyer</surname><given-names>O.</given-names></name><name><surname>Gribouval</surname><given-names>O.</given-names></name><etal/></person-group><article-title>NPHS2 mutations in steroid-resistant nephrotic syndrome: A mutation update and the associated phenotypic spectrum</article-title><source><italic>Human Mutation</italic></source><year>2014</year><volume>35</volume><issue>2</issue><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="other">2-s2.0-84891958291</pub-id><pub-id pub-id-type="doi">10.1002/humu.22485</pub-id><pub-id pub-id-type="pmid">24227627</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>P. C.</given-names></name><name><surname>Henikoff</surname><given-names>S.</given-names></name></person-group><article-title>Predicting deleterious amino acid substitutions</article-title><source><italic>Genome Research</italic></source><year>2001</year><volume>11</volume><issue>5</issue><fpage>863</fpage><lpage>874</lpage><pub-id pub-id-type="other">2-s2.0-0035026704</pub-id><pub-id pub-id-type="doi">10.1101/gr.176601</pub-id><pub-id pub-id-type="pmid">11337480</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramensky</surname><given-names>V.</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name><name><surname>Sunyaev</surname><given-names>S.</given-names></name></person-group><article-title>Human non-synonymous SNPs: server and survey</article-title><source><italic>Nucleic Acids Research</italic></source><year>2002</year><volume>30</volume><issue>17</issue><fpage>3894</fpage><lpage>3900</lpage><pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id><pub-id pub-id-type="other">2-s2.0-0036713510</pub-id><pub-id pub-id-type="pmid">12202775</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reese</surname><given-names>M. G.</given-names></name><name><surname>Eeckman</surname><given-names>F. H.</given-names></name><name><surname>Kulp</surname><given-names>D.</given-names></name><name><surname>Haussler</surname><given-names>D.</given-names></name></person-group><article-title>Improved splice site detection in Genie</article-title><source><italic>Journal of Computational Biology</italic></source><year>1997</year><volume>4</volume><issue>3</issue><fpage>311</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1089/cmb.1997.4.311</pub-id><pub-id pub-id-type="other">2-s2.0-0030787520</pub-id><pub-id pub-id-type="pmid">9278062</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Mao</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome</article-title><source><italic>Pediatric Nephrology</italic></source><year>2017</year><volume>32</volume><issue>7</issue><fpage>1181</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.1007/s00467-017-3590-y</pub-id><pub-id pub-id-type="pmid">28204945</pub-id></element-citation></ref><ref id="B30"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhandapani</surname><given-names>M. C.</given-names></name><name><surname>Venkatesan</surname><given-names>V.</given-names></name><name><surname>Rengaswamy</surname><given-names>N. B.</given-names></name><etal/></person-group><article-title>Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children</article-title><source><italic>Clinical and Experimental Nephrology</italic></source><year>2016</year><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1007/s10157-016-1237-0</pub-id><pub-id pub-id-type="other">2-s2.0-84980034142</pub-id></element-citation></ref><ref id="B31"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname><given-names>A. S. K.</given-names></name><name><surname>Vijayan</surname><given-names>M.</given-names></name><name><surname>Rajagopal</surname><given-names>S.</given-names></name><name><surname>Rajendiran</surname><given-names>P.</given-names></name><name><surname>Senguttuvan</surname><given-names>P.</given-names></name></person-group><article-title>WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome</article-title><source><italic>Molecular and Cellular Biochemistry</italic></source><year>2016</year><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="other">2-s2.0-84996848393</pub-id><pub-id pub-id-type="doi">10.1007/s11010-016-2889-5</pub-id></element-citation></ref><ref id="B29"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffer</surname><given-names>A.</given-names></name><name><surname>Unnisa</surname><given-names>W.</given-names></name><name><surname>Raju</surname><given-names>D.</given-names></name><name><surname>Jahan</surname><given-names>P.</given-names></name></person-group><article-title>NPHS2 mutation analysis and primary nephrotic syndrome in southern Indians</article-title><source><italic>Nephrology</italic></source><year>2014</year><volume>19</volume><issue>7</issue><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="other">2-s2.0-84902481965</pub-id><pub-id pub-id-type="doi">10.1111/nep.12241</pub-id><pub-id pub-id-type="pmid">24674236</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benetti</surname><given-names>E.</given-names></name><name><surname>Caridi</surname><given-names>G.</given-names></name><name><surname>Centi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>mRNA sequencing of a novel NPHS2 intronic mutation in a child with focal and segmental glomerulosclerosis</article-title><source><italic>Saudi Journal of Kidney Diseases and Transplantation</italic></source><year>2014</year><volume>25</volume><issue>4</issue><fpage>854</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.4103/1319-2442.135180</pub-id><pub-id pub-id-type="other">2-s2.0-84907669394</pub-id><pub-id pub-id-type="pmid">24969201</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basiratnia</surname><given-names>M.</given-names></name><name><surname>Yavarian</surname><given-names>M.</given-names></name><name><surname>Torabinezhad</surname><given-names>S.</given-names></name><name><surname>Erjaee</surname><given-names>A.</given-names></name></person-group><article-title>NPHS2 gene in steroid-resistant nephrotic syndrome: Prevalence, clinical course, and mutational spectrum in south-west Iranian children</article-title><source><italic>Iranian Journal of Kidney Diseases</italic></source><year>2013</year><volume>7</volume><issue>5</issue><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="other">2-s2.0-84884737011</pub-id><pub-id pub-id-type="pmid">24072147</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>V.</given-names></name><name><surname>Feehally</surname><given-names>J.</given-names></name><name><surname>Jones</surname><given-names>G.</given-names></name><name><surname>Robertson</surname><given-names>L.</given-names></name><name><surname>Nair</surname><given-names>D.</given-names></name><name><surname>Vasudevan</surname><given-names>P.</given-names></name></person-group><article-title>Steroid-resistant nephrotic syndrome with mutations in NPHS2 (podocin): Report from a three-generation family</article-title><source><italic>Clinical Kidney Journal</italic></source><year>2014</year><volume>7</volume><issue>3</issue><fpage>303</fpage><lpage>305</lpage><pub-id pub-id-type="other">2-s2.0-84901934084</pub-id><pub-id pub-id-type="doi">10.1093/ckj/sfu028</pub-id><pub-id pub-id-type="pmid">25852895</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurin</surname><given-names>L.-P.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Mottl</surname><given-names>A. K.</given-names></name><name><surname>Blyth</surname><given-names>E. R.</given-names></name><name><surname>Poulton</surname><given-names>C. J.</given-names></name><name><surname>Weck</surname><given-names>K. E.</given-names></name></person-group><article-title>Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis</article-title><source><italic>Nephrology Dialysis Transplantation</italic></source><year>2014</year><volume>29</volume><issue>11</issue><fpage>2062</fpage><lpage>2069</lpage><pub-id pub-id-type="other">2-s2.0-84929072114</pub-id><pub-id pub-id-type="doi">10.1093/ndt/gft532</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>P. J.</given-names></name><name><surname>Hall</surname><given-names>G.</given-names></name><name><surname>Wigfall</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation</article-title><source><italic>Clinical Kidney Journal</italic></source><year>2015</year><volume>8</volume><issue>5</issue><fpage>538</fpage><lpage>542</lpage><pub-id pub-id-type="other">2-s2.0-84954067457</pub-id><pub-id pub-id-type="doi">10.1093/ckj/sfv063</pub-id><pub-id pub-id-type="pmid">26413278</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi&#x00144;czak-Kuleta</surname><given-names>A.</given-names></name><name><surname>Rubik</surname><given-names>J.</given-names></name><name><surname>Litwin</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis &#x02013; A single-centre experience</article-title><source><italic>Bosnian Journal of Basic Medical Sciences</italic></source><year>2014</year><volume>14</volume><issue>2</issue><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="other">2-s2.0-84922393393</pub-id><pub-id pub-id-type="pmid">24856380</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suvanto</surname><given-names>M.</given-names></name><name><surname>Patrakka</surname><given-names>J.</given-names></name><name><surname>Jahnukainen</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern</article-title><source><italic>Clinical and Experimental Nephrology</italic></source><year>2016</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="other">2-s2.0-84984649218</pub-id><pub-id pub-id-type="doi">10.1007/s10157-016-1331-3</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kari</surname><given-names>J. A.</given-names></name><name><surname>El-Desoky</surname><given-names>S. M.</given-names></name><name><surname>Gari</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Steroid-resistant nephrotic syndrome: Impact of genetic testing</article-title><source><italic>Annals of Saudi Medicine</italic></source><year>2013</year><volume>33</volume><issue>6</issue><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="other">2-s2.0-84893488605</pub-id><pub-id pub-id-type="doi">10.5144/0256-4947.2013.533</pub-id><pub-id pub-id-type="pmid">24413855</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogino</surname><given-names>D.</given-names></name><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Analysis of the genes responsible for steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis in Japanese patients by whole-exome sequencing analysis</article-title><source><italic>Journal of Human Genetics</italic></source><year>2016</year><volume>61</volume><issue>2</issue><fpage>137</fpage><lpage>141</lpage><pub-id pub-id-type="other">2-s2.0-84959267898</pub-id><pub-id pub-id-type="doi">10.1038/jhg.2015.122</pub-id><pub-id pub-id-type="pmid">26467726</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasco-Miranda</surname><given-names>J. S.</given-names></name><name><surname>Garcia-Alvarez</surname><given-names>R.</given-names></name><name><surname>Sotelo-Mundo</surname><given-names>R. R.</given-names></name><name><surname>Valenzuela</surname><given-names>O.</given-names></name><name><surname>Islas-Osuna</surname><given-names>M. A.</given-names></name><name><surname>Sotelo-Cruz</surname><given-names>N.</given-names></name></person-group><article-title>Mutations in NPHS2 (podocin) in Mexican children with nephrotic syndrome who respond to standard steroid treatment</article-title><source><italic>Genetics and Molecular Research</italic></source><year>2013</year><volume>12</volume><issue>2</issue><fpage>2102</fpage><lpage>2107</lpage><pub-id pub-id-type="other">2-s2.0-84879912359</pub-id><pub-id pub-id-type="doi">10.4238/2013.June.24.1</pub-id><pub-id pub-id-type="pmid">23913389</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azocar</surname><given-names>M.</given-names></name><name><surname>Vega</surname><given-names>&#x000c1;.</given-names></name><name><surname>Farf&#x000e1;n</surname><given-names>M.</given-names></name><name><surname>Cano</surname><given-names>F.</given-names></name></person-group><article-title>NPHS2 Mutation analysis study in children with steroid-resistant nephrotic syndrome</article-title><source><italic>Revista Chilena de Pediatria</italic></source><year>2016</year><volume>87</volume><issue>1</issue><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="other">2-s2.0-84960365452</pub-id><pub-id pub-id-type="doi">10.1016/j.rchipe.2015.06.025</pub-id><pub-id pub-id-type="pmid">26455708</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guaragna</surname><given-names>M. S.</given-names></name><name><surname>Lutaif</surname><given-names>A. C. G. B.</given-names></name><name><surname>Piveta</surname><given-names>C. S. C.</given-names></name><etal/></person-group><article-title>NPHS2 mutations account for only 15% of nephrotic syndrome cases</article-title><source><italic>BMC Medical Genetics</italic></source><year>2015</year><volume>16</volume><issue>1, article 88</issue><pub-id pub-id-type="doi">10.1186/s12881-015-0231-9</pub-id><pub-id pub-id-type="other">2-s2.0-84942570381</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruf</surname><given-names>R. G.</given-names></name><name><surname>Lichtenberger</surname><given-names>A.</given-names></name><name><surname>Karle</surname><given-names>S. M.</given-names></name><etal/></person-group><article-title>Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome</article-title><source><italic>Journal of the American Society of Nephrology</italic></source><year>2004</year><volume>15</volume><issue>3</issue><fpage>722</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1097/01.asn.0000113552.59155.72</pub-id><pub-id pub-id-type="other">2-s2.0-10744226566</pub-id><pub-id pub-id-type="pmid">14978175</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megremis</surname><given-names>S.</given-names></name><name><surname>Mitsioni</surname><given-names>A.</given-names></name><name><surname>Mitsioni</surname><given-names>A. G.</given-names></name><etal/></person-group><article-title>Nucleotide variations in the NPHS2 gene in Greek children with steroid-resistant nephrotic syndrome</article-title><source><italic>Genetic Testing and Molecular Biomarkers</italic></source><year>2009</year><volume>13</volume><issue>2</issue><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1089/gtmb.2008.0083</pub-id><pub-id pub-id-type="other">2-s2.0-67650077702</pub-id><pub-id pub-id-type="pmid">19371226</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children</article-title><source><italic>Nephrology Dialysis Transplantation</italic></source><year>2005</year><volume>20</volume><issue>5</issue><fpage>902</fpage><lpage>908</lpage><pub-id pub-id-type="other">2-s2.0-18944383337</pub-id><pub-id pub-id-type="doi">10.1093/ndt/gfh769</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasudevan</surname><given-names>A.</given-names></name><name><surname>Siji</surname><given-names>A.</given-names></name><name><surname>Raghavendra</surname><given-names>A.</given-names></name><name><surname>Sridhar</surname><given-names>T. S.</given-names></name><name><surname>Phadke</surname><given-names>K. D.</given-names></name></person-group><article-title>NPHS2 mutations in Indian children with sporadic early steroid resistant nephrotic syndrome</article-title><source><italic>Indian Pediatrics</italic></source><year>2012</year><volume>49</volume><issue>3</issue><fpage>231</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1007/s13312-012-0057-x</pub-id><pub-id pub-id-type="other">2-s2.0-84863098126</pub-id><pub-id pub-id-type="pmid">22080622</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>K.</given-names></name><name><surname>Iijima</surname><given-names>K.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><etal/></person-group><article-title>NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children</article-title><source><italic>Pediatric Nephrology</italic></source><year>2003</year><volume>18</volume><issue>5</issue><fpage>412</fpage><lpage>416</lpage><pub-id pub-id-type="other">2-s2.0-10744233544</pub-id><pub-id pub-id-type="pmid">12687458</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abid</surname><given-names>A.</given-names></name><name><surname>Khaliq</surname><given-names>S.</given-names></name><name><surname>Shahid</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan</article-title><source><italic>Gene</italic></source><year>2012</year><volume>502</volume><issue>2</issue><fpage>133</fpage><lpage>137</lpage><pub-id pub-id-type="other">2-s2.0-84861341066</pub-id><pub-id pub-id-type="doi">10.1016/j.gene.2012.04.063</pub-id><pub-id pub-id-type="pmid">22565185</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H. Y.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Choi</surname><given-names>H. J.</given-names></name><etal/></person-group><article-title>WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome</article-title><source><italic>Pediatric Nephrology</italic></source><year>2008</year><volume>23</volume><issue>1</issue><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="other">2-s2.0-37049007433</pub-id><pub-id pub-id-type="doi">10.1007/s00467-007-0620-1</pub-id><pub-id pub-id-type="pmid">17934764</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Az&#x000f3;car</surname><given-names>M.</given-names></name></person-group><article-title>El S&#x000ed;ndrome Nefr&#x000f3;tico y el Diagn&#x000f3;stico Gen&#x000e9;tico en Pediatr&#x000ed;a</article-title><source><italic>Revista Chilena de Pediatr&#x000ed;a</italic></source><year>2011</year><volume>82</volume><issue>1</issue><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.4067/S0370-41062011000100002</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machuca</surname><given-names>E.</given-names></name><name><surname>Hummel</surname><given-names>A.</given-names></name><name><surname>Nevo</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant</article-title><source><italic>Kidney International</italic></source><year>2009</year><volume>75</volume><issue>7</issue><fpage>727</fpage><lpage>735</lpage><pub-id pub-id-type="other">2-s2.0-62349123713</pub-id><pub-id pub-id-type="doi">10.1038/ki.2008.650</pub-id><pub-id pub-id-type="pmid">19145239</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>(a) Map of the main countries where<italic> NPHS2 </italic>mutations have been studied so far in SRNS cohorts around the world (red circle marks). Latin America is highlighted in darker yellow, with the three main centers (Mexico, Chile, and Brazil), where<italic> NPHS2</italic> mutations had been published represented by black circle marks. (b) Pye charts representing the percentage of<italic> NPHS2 </italic>mutations (in orange) found in some countries from South Asia, East Asia, Europe, North America, and South America.</p></caption><graphic xlink:href="BMRI2017-7518789.001"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>
<italic>NPHS2</italic> variants described from June 2013 to February 2017<sup><italic>&#x02217;</italic></sup>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Exon/intron</th><th rowspan="2" align="center" colspan="1">Nucleotide change</th><th rowspan="2" align="center" colspan="1">Amino acid change</th><th colspan="2" align="center" rowspan="1">In silico prediction consequence</th><th rowspan="2" align="center" colspan="1">Ref.</th><th rowspan="2" align="center" colspan="1">Country</th></tr><tr><th align="center" rowspan="1" colspan="1">PolyPhen/score<sup>a</sup></th><th align="center" rowspan="1" colspan="1">SIFT/score<sup>b</sup></th></tr></thead><tbody><tr><td colspan="7" align="center" rowspan="1">Missense</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">c.133T&#x0003e;C</td><td align="center" rowspan="1" colspan="1">p.Ser46Pro</td><td align="center" rowspan="1" colspan="1">B/0.0</td><td align="center" rowspan="1" colspan="1">T/0.28</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1">India</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">c.415T&#x0003e;A</td><td align="center" rowspan="1" colspan="1">p.Leu139Arg</td><td align="center" rowspan="1" colspan="1">P/0.967</td><td align="center" rowspan="1" colspan="1">D/0.0</td><td align="center" rowspan="1" colspan="1">[<xref rid="B41" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">Mexico</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">c.500T&#x0003e;C</td><td align="center" rowspan="1" colspan="1">p.Leu167Pro</td><td align="center" rowspan="1" colspan="1">P/1.0</td><td align="center" rowspan="1" colspan="1">D/0.0</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1">India</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">c.523C&#x0003e;T</td><td align="center" rowspan="1" colspan="1">p.Pro175Ser</td><td align="center" rowspan="1" colspan="1">B/0.0</td><td align="center" rowspan="1" colspan="1">D/0.0</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1">India</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">c.946C&#x0003e;T</td><td align="center" rowspan="1" colspan="1">p.Pro316Ser</td><td align="center" rowspan="1" colspan="1">P/0.976</td><td align="center" rowspan="1" colspan="1">D/0.02</td><td align="center" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">30</xref>]</td><td align="center" rowspan="1" colspan="1">India</td></tr><tr><td colspan="7" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="2" align="left" colspan="1">Exon/intron</td><td rowspan="2" align="center" colspan="1">Nucleotide change</td><td rowspan="2" align="center" colspan="1">Amino acid change</td><td colspan="2" align="center" rowspan="1">Splice-site prediction by neural network</td><td rowspan="2" align="center" colspan="1">Ref.</td><td rowspan="2" align="center" colspan="1">Country</td></tr><tr><td align="center" rowspan="1" colspan="1">Score normal sequence</td><td align="center" rowspan="1" colspan="1">Score mutant sequence</td></tr><tr><td colspan="7" rowspan="1">
<hr/>
</td></tr><tr><td colspan="7" align="center" rowspan="1">Splice-site</td></tr><tr><td align="left" rowspan="1" colspan="1">Intron 3</td><td align="center" rowspan="1" colspan="1">c.451+3A&#x0003e;T</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">0.54</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">[<xref rid="B32" ref-type="bibr">32</xref>]</td><td align="center" rowspan="1" colspan="1">Italy</td></tr><tr><td align="left" rowspan="1" colspan="1">Intron 4</td><td align="center" rowspan="1" colspan="1">c.[53]5-1G&#x0003e;A</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">0.54</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>]</td><td align="center" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Intron 5</td><td align="center" rowspan="1" colspan="1">c.738+2T&#x0003e;C</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">0.90</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>]</td><td align="center" rowspan="1" colspan="1">China</td></tr><tr><td colspan="7" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Exon/intron</td><td align="center" rowspan="1" colspan="1">Nucleotide change</td><td align="center" rowspan="1" colspan="1">Amino acid change</td><td colspan="2" align="center" rowspan="1">Consequence</td><td align="center" rowspan="1" colspan="1">Ref.</td><td align="center" rowspan="1" colspan="1">Country</td></tr><tr><td colspan="7" rowspan="1">
<hr/>
</td></tr><tr><td colspan="7" align="center" rowspan="1">Frameshift</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">c.714delG</td><td align="center" rowspan="1" colspan="1">p.Lis239Argfs<sup><italic>&#x02217;</italic></sup>13</td><td colspan="2" align="center" rowspan="1">D</td><td align="center" rowspan="1" colspan="1">[<xref rid="B43" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">Brazil</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">c.988_989delCT</td><td align="center" rowspan="1" colspan="1">p.Ser329 = fs<sup><italic>&#x02217;</italic></sup>14</td><td colspan="2" align="center" rowspan="1">D</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1">Finland</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup><italic>&#x02217;</italic></sup>The variants presented in this table were not annotated in the public HGMD (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>) (access date May 31) or in the GnomeAD Browser (<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org">http://gnomad.broadinstitute.org</ext-link>) (access date May 31) or in the Leiden Open Variation Database (<ext-link ext-link-type="uri" xlink:href="https://www.lovd.nl/NPHS2">https://www.lovd.nl/NPHS2</ext-link>) (access date May 31); <sup>a</sup>PolyPhen: 1.000 = probably damaging (P); 0.5000 = possibly damaging (PO); 0.000 = benign (B). <sup>b</sup>SIFT: &#x02264;0.05 = damaging (D); &#x0003e;0.05 = tolerated (T).</p></fn></table-wrap-foot></table-wrap></floats-group></article>